---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-046776"
form_type: "8-K"
ticker: null
cik: "0000827871"
company_name: "EAGLE PHARMACEUTICALS, INC."
filed_at: "2024-04-12T23:59:59+00:00"
generated_at: "2026-06-03T23:44:32.216665+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Eagle Pharma faces potential Nasdaq delisting after 10-K delay; may miss extension deadline

## Summary
- Received Nasdaq notice on April 8 for failure to timely file FY 2023 Form 10-K; prior Q3 10-Q also late.
- Company previously granted extension to May 13, 2024 to regain compliance; must submit updated plan by April 23.
- Company believes it is unlikely to file Form 10-Q or 10-K by May 13 extension deadline.
- Nasdaq may accelerate delisting; company could request hearing to stay suspension.

## SEC filing metadata
- accession: 0001104659-24-046776
- form_type: 8-K
- cik: 0000827871
- company_name: EAGLE PHARMACEUTICALS, INC.
- filed_at: 2024-04-12T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/827871/000110465924046776/0001104659-24-046776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/827871/000110465924046776/tm2411717d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-046776
- JSON: https://secwatch.observer/filing/0001104659-24-046776.json
- Plain text: https://secwatch.observer/filing/0001104659-24-046776.txt

## Key facts
- Listing & Compliance Notices
  EAGLE PHARMACEUTICALS, INC. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).
  - Exchange: nasdaq
  - Notice: noncompliance notice
  - Deficiency: late filing
  - Rules: 5250(c)(1)
  source text: April 8, 2024, Eagle Pharmaceuticals , Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that due to the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”), with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires the timely filing of all required periodic reports with t
  evidence_url: https://www.sec.gov/Archives/edgar/data/827871/000110465924046776/0001104659-24-046776-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.